AU2001246883A1 - Stabilized pharmaceutical compositions containing calcium channel blockers - Google Patents

Stabilized pharmaceutical compositions containing calcium channel blockers

Info

Publication number: AU2001246883A1
Authority: AU; Australia
Prior art keywords: pharmaceutical compositions; compositions containing; calcium channel; channel blockers; containing calcium
Prior art date: 2000-04-11
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2001246883A

Other versions

AU2001246883B2 (en

Inventor

Kenji Nishimura

Fusao Usui

Naoki Wakiyama

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sankyo Co Ltd

Ube Corp

Original Assignee

Sankyo Co Ltd

Ube Industries Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-04-11

Filing date

2001-04-10

Publication date

2002-01-10

2001-04-10 Application filed by Sankyo Co Ltd, Ube Industries Ltd filed Critical Sankyo Co Ltd

2001-04-10 Priority claimed from PCT/JP2001/003087 external-priority patent/WO2001076598A1/en

2002-01-10 Publication of AU2001246883A1 publication Critical patent/AU2001246883A1/en

2003-12-04 Assigned to UBE INDUSTRIES LIMITED, SANKYO COMPANY, LIMITED reassignment UBE INDUSTRIES LIMITED Request for Assignment Assignors: SANKYO COMPANY, LIMITED

2004-08-12 Application granted granted Critical

2004-08-12 Publication of AU2001246883B2 publication Critical patent/AU2001246883B2/en

2021-04-10 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Links

229940030609 CALCIUM CHANNEL BLOCKERS Drugs 0.000 title 1
239000000480 calcium channel blocker Substances 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

AU2001246883A 2000-04-11 2001-04-10 Stabilized pharmaceutical compositions containing calcium channel blockers Ceased AU2001246883B2 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2000-108850		2000-04-11
JP2000108850		2000-04-11
PCT/JP2001/003087 WO2001076598A1 (en)	2000-04-11	2001-04-10	Stabilized pharmaceutical compositions containing calcium channel blockers

Publications (2)

Publication Number	Publication Date
AU2001246883A1 true AU2001246883A1 (en)	2002-01-10
AU2001246883B2 AU2001246883B2 (en)	2004-08-12

Family

ID=18621626

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AU2001246883A Ceased AU2001246883B2 (en)	2000-04-11	2001-04-10	Stabilized pharmaceutical compositions containing calcium channel blockers
AU4688301A Pending AU4688301A (en)	2000-04-11	2001-04-10	Stabilized pharmaceutical compositions containing calcium channel blockers

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AU4688301A Pending AU4688301A (en)	2000-04-11	2001-04-10	Stabilized pharmaceutical compositions containing calcium channel blockers

Country Status (23)

Country	Link
US (4)	US20030073670A1 (en)
EP (1)	EP1285655B1 (en)
JP (1)	JP2009143923A (en)
KR (1)	KR100756565B1 (en)
CN (1)	CN100450483C (en)
AT (1)	ATE363281T1 (en)
AU (2)	AU2001246883B2 (en)
BR (1)	BR0109991A (en)
CA (1)	CA2405046C (en)
CZ (1)	CZ301790B6 (en)
DE (1)	DE60128683T2 (en)
ES (1)	ES2287110T3 (en)
HK (1)	HK1050324A1 (en)
HU (1)	HUP0300444A3 (en)
IL (2)	IL152021A0 (en)
MX (1)	MXPA02010040A (en)
NO (1)	NO329943B1 (en)
NZ (1)	NZ521853A (en)
PL (1)	PL201513B1 (en)
RU (1)	RU2239432C2 (en)
TW (1)	TWI246921B (en)
WO (1)	WO2001076598A1 (en)
ZA (1)	ZA200207933B (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3595765B2 (en) *	2000-09-27	2004-12-02	信越化学工業株式会社	Base for dry direct hitting containing low substituted hydroxypropylcellulose
MXPA05006885A (en) *	2002-12-24	2005-08-16	Sankyo Co	Optically active dihydropyridine derivative.
AU2004208615C1 (en) *	2003-01-31	2010-05-13	Daiichi Sankyo Company, Limited	Medicine for prevention of and treatment for arteriosclerosis and hypertension
DK1628663T3 (en)	2003-05-15	2010-03-08	Roskamp Res Llc	Process for the preparation of medicaments for reducing amyloid deposition, amyloid neurotoxicity and microgliosis
CN1762354B (en) *	2004-10-18	2010-07-28	上海药明康德新药开发有限公司	Stable pharmaceutical composition containing calcium blocker
US20070042049A1 (en) *	2005-06-03	2007-02-22	Elan Pharma International, Limited	Nanoparticulate benidipine compositions
EP1931340A2 (en) *	2005-06-15	2008-06-18	Elan Pharma International Limited	Nanoparticulate azelnidipine formulations
KR20130135994A (en) *	2005-06-27	2013-12-11	다이이찌 산쿄 가부시키가이샤	Pharmaceutical preparation containing an angiotensin ii receptor antagonist and a calcium channel blocker
TW200736245A (en) *	2005-11-29	2007-10-01	Sankyo Co	Acid addition salts of optically active dihydropyridine derivatives
TW200806648A (en) *	2005-11-29	2008-02-01	Sankyo Co	Acid addition salts of dihydropyridine derivatives
CN101103979B (en) *	2006-07-14	2010-12-08	海南盛科生命科学研究院	Azelnidipine medicinal composition and its preparing method
TWI399223B (en) *	2006-09-15	2013-06-21	Daiichi Sankyo Co Ltd	Solid dosage form of olmesartan medoxomil and amlodipine
GB0709541D0 (en) *	2007-05-17	2007-06-27	Jagotec Ag	Pharmaceutical excipient
JP2008290989A (en) *	2007-05-28	2008-12-04	Ube Ind Ltd	Pharmaceutical comprising acid addition salt of dihydropyridine derivative
DK2214666T3 (en)	2007-10-05	2014-01-27	Alzheimer S Inst Of America Inc	METHOD FOR REDUCING AMYLOID DEPOSIT, AMYLOID NEUROTOXICITY AND MICROGLIOSIS WITH (-) - NILVADIPIN ENANTIOMES
EP2307022A4 (en) *	2007-10-31	2011-08-24	Equitech Corp	Enhanced nsaid formulations
NZ594513A (en)	2009-03-04	2013-10-25	Orexo Ab	Abuse resistant formulation
EP2427177B1 (en)	2009-05-08	2018-03-28	Emplicure AB	Composition for sustained drug delivery comprising geopolymeric binder
CA2809927C (en)	2010-09-07	2019-08-20	Orexo Ab	A transdermal drug administration device
JP5917034B2 (en) *	2011-07-15	2016-05-11	ニプロ株式会社	Solid pharmaceutical composition containing calcium blocker
US8679547B2 (en) *	2011-10-20	2014-03-25	Tomita Pharmaceutical Co., Ltd.	Method for manufacturing calcium silicate based composition
CN102921008B (en) *	2012-11-16	2014-01-01	南京正大天晴制药有限公司	Stable drug composition containing calcium blockers
CN104473888B (en) *	2014-11-20	2017-01-18	南京正大天晴制药有限公司	Pharmaceutical composition of azelnidipine
JP6462625B2 (en) *	2016-04-06	2019-01-30	ニプロ株式会社	Tablets containing calcium blockers
JP6426115B2 (en) *	2016-04-06	2018-11-21	ニプロ株式会社	Solid pharmaceutical composition containing a calcium blocker

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1670827C3 (en) *	1967-03-20	1974-10-24	Bayer Ag, 5090 Leverkusen	4- (2'-nitrophenyl) -2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridine
DE2117571C3 (en) *	1971-04-10	1979-10-11	Bayer Ag, 5090 Leverkusen	Asymmetrical 1,4-dihydropyridine-33-dicarboxylic acid esters, process for their preparation and their use as pharmaceuticals
US3985758A (en) *	1973-02-20	1976-10-12	Yamanouchi Pharmaceutical Co., Ltd.	1,4-Dihydropyridine derivatives
US4338322A (en) *	1975-07-02	1982-07-06	Fujisawa Pharmaceutical Co., Ltd.	1,4-Dihydropyridine derivatives, pharmaceutical compositions containing same and methods of effecting vasodilation using same
US4154839A (en) *	1975-11-05	1979-05-15	Bayer Aktiengesellschaft	2,6-Dimethyl-3-carboxymethoxy-4-(2-nitrophenyl)-5-carbisobutoxy-1,4-dihydropyridine
JPS55301A (en) *	1978-02-14	1980-01-05	Yamanouchi Pharmaceut Co Ltd	1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its preparation
SE429652B (en) *	1978-06-30	1983-09-19	Haessle Ab	2,6-dimethyl-4- (2,3-dichlorophenyl) -1,4-dihydropyridine-3,5-dicarboxylic acid 3-methyl 5-ethyl ester
GB2111978B (en) *	1981-10-19	1985-05-01	Maruko Pharmaceutical Co	1 4-dihydropyridine compounds
DK161312C (en) *	1982-03-11	1991-12-09	Pfizer	CHANGES FOR THE PREPARATION FOR THE PREPARATION OF 2-Amino-CO-Methyl-4-Methyl-4-Methyl-4-Methyl-4-Methyl-4-Methyl-4-Methyl-2-D-Hydroxy
WO1983003249A1 (en) *	1982-03-17	1983-09-29	Yoshitomi Pharmaceutical	1,4-dihydropyridine-3,5-dicarboxylate derivatives
EP0094159B1 (en) *	1982-05-10	1990-03-14	Takeda Chemical Industries, Ltd.	Dihydropyridine derivatives, their production and use
JPS59225162A (en) *	1983-06-03	1984-12-18	Kyowa Hakko Kogyo Co Ltd	1,4-dihydropyridine derivative
US4656181A (en) *	1982-11-24	1987-04-07	Cermol S.A.	Esters of 1,4-dihydropyridines, processes for the preparation of the new esters, and medicaments containing the same
JPS59101423A (en) *	1982-12-02	1984-06-12	Takada Seiyaku Kk	Novel solid pharmaceutical preparation of nifedipine
US4520112A (en) *	1983-03-09	1985-05-28	The Johns Hopkins University	Assay method for organic calcium antagonist drugs and a kit for such an assay
JPS60120861A (en) *	1983-12-02	1985-06-28	Otsuka Pharmaceut Co Ltd	Dihydropyridine derivative
US4672068A (en) *	1984-05-04	1987-06-09	Fujirebio Kabushiki Kaisha	Antihypertensive 1,4-dihydropyridines having a conjugated ester
US4794111A (en) *	1984-05-23	1988-12-27	Bayer Aktiengesellschaft	Dihydropyridine preparations containing β-blockers
FI853477L (en) *	1984-09-14	1986-03-15	Ciba Geigy Ag	FOER FARING FOER FRAMSTAELLNING AV KARBONYLFOERENINGAR.
US4762950A (en) *	1985-12-16	1988-08-09	Basf Corporation	Selective oxyalkylaton of N-(2-hydroxyalkyl)-aniline
US4885284A (en) *	1986-01-22	1989-12-05	Nissan Chemical Industries Ltd.	Dihydropyridine-5-phosphonic acid cyclic propylene ester
US5198226A (en) *	1986-01-30	1993-03-30	Syntex (U.S.A.) Inc.	Long acting nicardipine hydrochloride formulation
US4940556A (en) *	1986-01-30	1990-07-10	Syntex (U.S.A.) Inc.	Method of preparing long acting formulation
SE8601624D0 (en) *	1986-04-11	1986-04-11	Haessle Ab	NEW PHARMACEUTICAL PREPARATIONS
US4772596A (en) *	1986-10-09	1988-09-20	Sankyo Company Limited	Dihydropyridine derivatives, their preparation and their use
JPS6396126A (en) *	1986-10-13	1988-04-27	Taisho Pharmaceut Co Ltd	Stabilized composition
ATE61588T1 (en) *	1987-08-03	1991-03-15	Delagrange Lab	1,4-DIHYDROPYRIDINES, PROCESSES FOR THEIR PRODUCTION AND USE AS MEDICINAL PRODUCTS.
SE8703881D0 (en) *	1987-10-08	1987-10-08	Haessle Ab	NEW PHARMACEUTICAL PREPARATION
SU1722252A3 (en) *	1988-06-15	1992-03-23	Сименс Аг (Фирма)	Device for eddy-current inspection of heat-exchanger with u- shaped tubes
US5484789A (en) *	1989-10-31	1996-01-16	The University Of North Carolina At Chapel Hill	Calcium channel blockers to improve preservation of organs stored for transplantation
US5209933A (en) *	1990-01-10	1993-05-11	Syntex (U.S.A.) Inc.	Long acting calcium channel blocker composition
GB2245559A (en) *	1990-06-25	1992-01-08	Farmos Oy	Bioceramic system for delivery of a bioactive compound.
US5209993A (en) *	1990-08-24	1993-05-11	General Motors Corporation	Method of enveloping battery plates
JP3110794B2 (en) *	1991-06-05	2000-11-20	ユーシービージャパン株式会社	Preparation containing 1,4-dihydropyridine derivative
HU9203780D0 (en) *	1991-12-12	1993-03-29	Sandoz Ag	Stabilized pharmaceutical products of hmg-coa reductase inhibitor and method for producing them
US5958458A (en) *	1994-06-15	1999-09-28	Dumex-Alpharma A/S	Pharmaceutical multiple unit particulate formulation in the form of coated cores
US5760238A (en) *	1994-08-29	1998-06-02	Mercian Corporation	1,4-dihydropyridine derivatives
JPH10167966A (en) *	1996-12-03	1998-06-23	Nippon Chemiphar Co Ltd	Oral sustained release preparation
ES2125198B1 (en) *	1997-05-13	1999-11-16	Vita Invest Sa	FIXED-DOSE ASSOCIATION OF AN ANGIOTENSIN CONVERTING ENZYME INHIBITOR AND AN ANTAGONIST OF THE CALCIUM CHANNELS, PROCEDURE FOR ITS PREPARATION AND USE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES.
JP3491506B2 (en) *	1997-10-14	2004-01-26	宇部興産株式会社	Method for producing dihydropyridine derivative
SE9704400D0 (en) *	1997-11-28	1997-11-28	Astra Ab	Porous inorganic particles as carriers for drug substances
US6753011B2 (en) *	2000-01-14	2004-06-22	Osmotica Corp	Combined diffusion/osmotic pumping drug delivery system
CZ20031069A3 (en) *	2000-10-26	2004-05-12	Pfizeráproductsáinc	Metalloproteinase pyrimidine-2,4,6-trione inhibitors
MXPA03005886A (en) *	2000-12-29	2005-04-19	Pfizer Ltd	Aspartate derivative of amlodipine as calcium channel antagonist.
IL161448A0 (en) *	2001-10-24	2004-09-27	Sepracor Inc	Method of resolving amlodipine racemate

2001
- 2001-04-10 KR KR1020027013417A patent/KR100756565B1/en not_active IP Right Cessation
- 2001-04-10 TW TW090108557A patent/TWI246921B/en not_active IP Right Cessation
- 2001-04-10 EP EP01919870A patent/EP1285655B1/en not_active Expired - Lifetime
- 2001-04-10 DE DE60128683T patent/DE60128683T2/en not_active Expired - Lifetime
- 2001-04-10 AT AT01919870T patent/ATE363281T1/en not_active IP Right Cessation
- 2001-04-10 IL IL15202101A patent/IL152021A0/en unknown
- 2001-04-10 HU HU0300444A patent/HUP0300444A3/en unknown
- 2001-04-10 ES ES01919870T patent/ES2287110T3/en not_active Expired - Lifetime
- 2001-04-10 CZ CZ20023353A patent/CZ301790B6/en not_active IP Right Cessation
- 2001-04-10 PL PL357572A patent/PL201513B1/en not_active IP Right Cessation
- 2001-04-10 AU AU2001246883A patent/AU2001246883B2/en not_active Ceased
- 2001-04-10 AU AU4688301A patent/AU4688301A/en active Pending
- 2001-04-10 CN CNB018109438A patent/CN100450483C/en not_active Expired - Fee Related
- 2001-04-10 CA CA002405046A patent/CA2405046C/en not_active Expired - Fee Related
- 2001-04-10 MX MXPA02010040A patent/MXPA02010040A/en active IP Right Grant
- 2001-04-10 RU RU2002127125/15A patent/RU2239432C2/en not_active IP Right Cessation
- 2001-04-10 NZ NZ521853A patent/NZ521853A/en not_active IP Right Cessation
- 2001-04-10 WO PCT/JP2001/003087 patent/WO2001076598A1/en active IP Right Grant
- 2001-04-10 BR BR0109991-4A patent/BR0109991A/en not_active IP Right Cessation
2002
- 2002-09-30 IL IL152021A patent/IL152021A/en not_active IP Right Cessation
- 2002-10-02 ZA ZA200207933A patent/ZA200207933B/en unknown
- 2002-10-10 US US10/268,308 patent/US20030073670A1/en not_active Abandoned
- 2002-10-10 NO NO20024885A patent/NO329943B1/en not_active IP Right Cessation
2003
- 2003-04-09 HK HK03102533A patent/HK1050324A1/en not_active IP Right Cessation
2007
- 2007-02-08 US US11/704,122 patent/US20070142442A1/en not_active Abandoned
2008
- 2008-12-16 JP JP2008319561A patent/JP2009143923A/en active Pending
2010
- 2010-02-03 US US12/658,202 patent/US20100144697A1/en not_active Abandoned
- 2010-02-03 US US12/658,201 patent/US20100144696A1/en not_active Abandoned

Publication	Publication Date	Title
AU2001246883A1 (en)	2002-01-10	Stabilized pharmaceutical compositions containing calcium channel blockers
HUP0300444A3 (en)	2007-09-28	Stabilized pharmaceutical compositions containing calcium channel blockers
AU781269C (en)	2006-11-30	Pharmaceutical compositions
AU2001250420A1 (en)	2001-10-23	Pharmaceutical compositions
AU2001274307A1 (en)	2002-01-02	Pharmaceutical compositions
AU2002313236A1 (en)	2003-05-15	Medicinal compositions
AU6219601A (en)	2001-10-30	Pharmaceutical compositions
AU2001233691A1 (en)	2001-07-24	Antiperspirant compositions
AU4413299A (en)	1999-12-20	Stabilized pharmaceutical compositions
AU2002217464A1 (en)	2003-01-23	Medicinal compositions containing aspirin
AU2002216059A1 (en)	2002-06-24	Oral bleaching composition
AU2001285790A1 (en)	2002-01-21	Antiperspirant compositions
AU2002258221A1 (en)	2003-05-08	Medicinal composition
AU8576801A (en)	2002-01-02	Pharmaceutical compositions
AU2001290239A1 (en)	2002-04-02	Medicinal composition
AU2002230664A1 (en)	2002-09-05	Reduced byproduct high solids polyamine-epihalohydrin compositions
AU2002221115A1 (en)	2002-06-24	Medicinal compositions having improved absorbability
AU1390002A (en)	2002-03-22	Pharmaceutical compositions
AU2001273919A1 (en)	2001-10-23	Pharmaceutical compositions
AU2001251321A1 (en)	2001-11-07	Vancomycin analogs
AU2001245615A1 (en)	2001-11-12	Pouched composition
AU2001270235A1 (en)	2002-01-14	Oral compositions
EP1404301A4 (en)	2006-03-22	Stable controlled release pharmaceutical compositions containing pravastatin
AU4085201A (en)	2001-09-24	Pharmaceutical composition
AU2000278051A1 (en)	2001-09-03	Stabilized emulsion compositions